UBS Raises Price Target on Dentsply Int'l (XRAY) to $67; Reiterates Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Dentsply Int'l (XRAY) Tops Q3 EPS by 3c; Boosts FY16 EPS Outlook
November 4, 2016 6:40 AM EDTDentsply Int'l (NASDAQ: XRAY) reported Q3 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $954.2 million versus the consensus estimate of $967.68 million.
GUIDANCE:
Dentsply Int'l sees FY2016 EPS of $2.75 - $2.80, versus the consensus of... More
